Abstract
Genetic Engineering & Biotechnology NewsVol. 42, No. 4 DepartmentsDiscovery-to-Clinic Path Smoothed by Open Source ManufacturingWheeler Bio says that its Portable CMC services can help drug developers and CROs streamline scale-up efforts and expedite IND programsGail DuttonGail DuttonSearch for more papers by this authorPublished Online:5 Apr 2022https://doi.org/10.1089/gen.42.04.06AboutSectionsView articleView Full TextPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View articleFiguresReferencesRelatedDetails Volume 42Issue 4Apr 2022 Information© 2022 by GEN PublishingTo cite this article:Gail Dutton.Discovery-to-Clinic Path Smoothed by Open Source Manufacturing.Genetic Engineering & Biotechnology News.Apr 2022.16-17.http://doi.org/10.1089/gen.42.04.06Published in Volume: 42 Issue 4: April 5, 2022PDF download
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
